Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07240012
NA

Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes

Sponsor: Rigshospitalet, Denmark

View on ClinicalTrials.gov

Summary

A national multi-center open-label randomized controlled trial that investigates whether the use of the automated insulin delivery system CamAPS FX initiated during pregnancy planning or in early pregnancy improves maternal time in glycemic targets and fetal growth in women with type 1 diabetes compared to usual insulin treatment modality combined with Continuous Glucose Monitoring.

Key Details

Gender

FEMALE

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

305

Start Date

2025-12-01

Completion Date

2028-10

Last Updated

2026-01-14

Healthy Volunteers

No

Interventions

DEVICE

Automated closed-loop insulin delivery

Automated closed-loop insulin delivery and The mylife CamAPS FX algorithm combined with CGM

Locations (8)

Department of Gynecology and Obstetrics, Aalborg University Hospital

Aalborg, Aalborg, Denmark

Department of Gynecology and Obstetrics, Aarhus University Hospital

Aarhus, Aarhus N, Denmark

Steno Diabetes Center Aarhus

Aarhus, Aarhus N, Denmark

Steno Diabetes Center Nordjylland

Aalborg, Gistrup, Denmark

Steno Diabetes Center Copenhagen

Copenhagen, Herlev, Denmark

Department of Gynecology and Obstetrics, Odense University Hospital

Odense, Odense C, Denmark

Steno Diabetes Center Odense, Odense University Hospital

Odense, Odense C, Denmark

Center for Pregnant Women with Diabetes, Rigshospitalet

Copenhagen, Denmark